Jiangsu Hengrui Pharmaceuticals(01276): On September 4th, the company repurchased 270,000 A shares.

Jiangsu Hengrui Pharmaceuticals (01276) announced that on September 4, 2025, the company repurchased 270,000 A-shares through centralized bidding trading for the first time. The repurchased shares account for 0.004% of the company's total share capital. The highest price of the transaction was 67.97 yuan/share, and the lowest price was 67.75 yuan/share. The total amount paid was 18.3139 million yuan (excluding transaction fees). The repurchase mentioned above is in compliance with relevant laws and regulations and the company's established share repurchase plan.